MDS is a bone marrow failure disorder

- Featured News and Events -

- GET ANSWERS -

Look for Hematology Oncologist in Rural N.Y./Pennsylvania area
Hello, My mother had RARS MDS. She is 79 years of age. She has been managed ...
8 hours, 1 minute ago
diagnosed 2 yrs ago.
Hi, I am 57 yrs old and diagnosed 2 yrs ago. I have so many questions and ...
2 days, 5 hours ago
Question re Max # of Transfusions
Does anyone know the maximum # of blood transfusions you can safely have with ...
5 days, 10 hours ago

- GET TREATMENT -

CENTERS OF EXCELLENCE
Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:
  • An established university (or equivalent) program
  • Recognized morphologic expertise in MDS
  • Available cytogenetics and/or molecular genetics
  • Ongoing research, including Institutional Review Board-approved clinical trials
  • Documentation of peer-reviewed publications in the field
LEARN MORE
CLINICAL TRIALS
Clinical trials study new interventions (drugs or procedures) to evaluate their safety and effectiveness in humans. Trials follow a careful set of steps, allowing for the systematic gathering of information to answer questions and confirm hypotheses that were formed earlier, in either laboratory experiments or preliminary trials. If you are an MDS patient, you may wish to discuss a trial with your primary treating physician to see if you qualify as a candidate. LEARN MORE
 
RECENT NEWS
Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH
SAN FRANCISCO--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced results from an international phase III study of REVLIMID® (lenali LEARN MORE
VI. International Eurasian Congress of Hematology
CONGRESSINVITATION from the Hematology Specialists Association, Turkey:   Dear Colleagues, We are pleased to announce that VI. Internatio LEARN MORE
CONNECT WITH US
Review answers to commonly asked questions or get answers to your questions from an MDS expert